Search Results 861-870 of 15775 for Residual

  1. LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009) - Mayo Clinic

    Subject has residual volume (RV) ≥175% predicted. Subject has stopped smoking for at least 8 weeks prior to entering the study, as confirmed by a Cotinine ...

  2. ARID II - Mayo Clinic

    Post void residual >200 milliliter (ml) or > 25 percentage (%) voiding volume 6. Presence of urethral stricture or bladder neck contracture 7. History of ...

  3. Eliminating Breast Cancer Surgery in Exceptional Responders with Neoadjuvant Systemic Therapy - Mayo Clinic

    ... residual carcinoma the patient will be taken off study. * Cohort B1 and B2 ? Conditions for patient eligibility: Patients on this portion of the study will ...

  4. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

    (Subjects with residual Grade 1 toxicity, for example Grade 1 peripheral neuropathy or residual alopecia, are allowed with approval of the Medical Monitor.) ...

  5. Arnab Basu - Doctors and Medical Staff - Mayo Clinic

    He is a recipient of the Young Investigator Award from the National Comprehensive Cancer Network. Interests. Kidney Cancer; Bladder Cancer; Minimal Residual ...

  6. Treatment of Symptomatic Bloating Using a Novel Hypnotherapy Protocol - Mayo Clinic

    Patients who have a history of cognitive delay, traumatic brain injury with residual deficits, history of cerebral vascular accident with residual deficiencies ...

  7. Lung Volume Reduction Coil Treatment In Patients With Emphysema (RENEW) Study - Mayo Clinic

    Subject has residual volume (RV) greater than or equal to 175% predicted; Subject has marked dyspnea greater than or equal to 2 on mMRC scale of 0-4; Subject ...

  8. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Clinical Trials - Mayo Clinic Research

    Patients will be randomized at the time of iCRS (iCRS must achieve no gross residual disease or no disease >1.0 cm in largest diameter) to receive HIPEC ... .

  9. Publications - Daniel Honore Lachance, M.D. - Mayo Clinic

    2018 Mar; 28(2):172-182. Epub 2017 Apr 02. View PubMed; Korfiatis P, Kline TL, Lachance DH, Parney IF, Buckner JC, Erickson BJ. Residual Deep Convolutional ...

  10. Biological Age And Outcomes In PCI - Mayo Clinic

    Prior stroke with significant residual neurological deficit; advanced dementia; severe Parkinson's disease; life expectancy <1 year due to non-cardiac ...